NCT05484622 · Interventional trial
Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma
Overall registry status Active not recruiting
Phase 1
Conditions Astrocytoma, Oligodendroglioma
Delaware Valley sites
- University of Pennsylvania Health System · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory